yemenjmedYemen Journal of MedicinecoVolume 4 Issue 3MultidisciplinaryEnglishSeptember- December 2025NNY20251231ArticleA Clinical Review of Continuous Renal Replacement Therapy: Modalities, Indications, and Management in Critical CareEnglishY492506ElmukhtarHabas1EnglishNAlaHabas2EnglishYAmnnaRayani3EnglishYKhaledAlarabi4EnglishY10.63475/yjm.v4i3.0259Continuous renal replacement therapy (CRRT) is a cornerstone of contemporary intensive care for patients experiencing severe acute kidney injury (AKI), especially in cases involving hemodynamic instability or multiorgan dysfunction. In contrast to intermittent modalities, CRRT facilitates gradual and continuous removal of solutes and fluids, thereby enhancing hemodynamic stability and enabling precise metabolic regulation. This review synthesizes existing evidence and practice, outlining the pathophysiology of AKI in critical illness and the technical specifications of core CRRT modalities: Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF). It analyzes the evidence-based indications and optimal timing for initiation, highlighting the shift from early empirical use to a strategy guided by specific clinical criteria. The review delineates fundamental operational principles, encompassing dosing (20–25 mL/kg/h effluent), fluid management, and the pivotal function of regional citrate anticoagulation. The prevention and management of complications, particularly electrolyte disturbances such as hypophosphatemia, nutrient depletion, and altered drug pharmacokinetics, is a primary focus. The analysis focuses on key controversies surrounding the application of CRRT for blood purification in sepsis. This discussion situates CRRT within the wider framework of organ support, emphasizing future advancements in personalized medicine, integrated sorbent technologies, and wearable devices. This review outlines a framework for clinicians to enhance CRRT delivery and improve outcomes for critically ill patients, while recognizing the limitations in the evidence base and global accessibility.EnglishContinuous renal replacement therapy (CRRT), acute kidney injury (AKI), critical care, hemodiafiltration, regional citrate anticoagulation, drug dosing, metabolic complicationshttps://www.yemenjmed.com/admin/abstract?id=288References16191. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949-1964.2. Mehta RL, Cerdand;aacute; J, Burdmann EA, Tonelli M, Garcand;iacute;a-Garcand;iacute;a G, Jha V, et al. International Society of Nephrologyand;rsquo;s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): A human rights case for nephrology. Lancet. 2015;385(9987):2616-2643.3. Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-1423.4. Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10): 607-625.5. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34(7): 1913-1917.6. Post EH, Kellum JA, Bellomo R, Vincent JL. Renal perfusion in sepsis: From macro- to microcirculation. Kidney Int. 2017;91(1):45-60.7. Perazella MA, Rosner MH. Drug-induced acute kidney injury. Clin J Am Soc Nephrol. 2022;17(8):1220-1233.8. Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649-672.9. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.10. Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, et al; Sapphire Investigators. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. 2014; 29(11):2054-2061.11. Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on Acute Kidney Injury Biomarkers from the Acute Disease Quality Initiative Consensus Conference: A consensus statement. JAMA Netw Open. 2020;3(10):e2019209.12. Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58-66.13. Bottari G, Ranieri VM, Ince C, Pesenti A, Aucella F, Scandroglio AM, et al. Use of extracorporeal blood purification therapies in sepsis: The current paradigm, available evidence, and future perspectives. Crit Care. 2024;28(1):432.14. Tandukar S, Palevsky PM. Continuous renal replacement therapy: Who, when, why, and how. Chest. 2019;155(3): 626-638.15. Lang T, Zawada AM, Theis L, Braun J, Ottillinger B, Kopperschmidt P, et al. Hemodiafiltration: Technical and medical insights. Bioengineering (Basel). 2023;10(2):145.16. Villa G, Neri M, Bellomo R, Cerda J, De Gaudio AR, De Rosa S, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: Practical applications. Crit Care. 2016;20(1):283.17. Murugan R, Hoste E, Mehta RL, Samoni S, Ding X, Rosner MH, et al; Acute Disease Quality Initiative (ADQI) Consensus Group. Precision fluid management in continuous renal replacement therapy. Blood Purif. 2016; 42(3):266-278.18. Gaudry S, Palevsky PM, Dreyfuss D. Extracorporeal kidney-replacement therapy for acute kidney injury. N Engl J Med. 2022;386(10):964-975.19. Bart BA, Goldsmith SR, Lee KL, Givertz MM, Oand;rsquo;Connor CM, Bull DA, et al; Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24): 2296-2304.20. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2(1):1-138.21. Chen H, Yu RG, Yin NN, Zhou JX. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: A systematic review. Crit Care. 2014;18(6):675.22. Ostermann M, Joannidis M, Pani A, Floris M, De Rosa S, Villa G, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif. 2016;42(3):224-237.23. Pickkers P, Vassiliou T, Liguts V, Prato F, Tissieres P, Kloesel S, et al. Sepsis management with a blood purification membrane: European experience. Blood Purif. 2019;47 Suppl 3:1-9.24. Gaudry S, Hajage D, Benichou N, Chaand;iuml;bi K, Barbar S, Zarbock A, et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: A systematic review and individual patient data metaanalysis of randomised clinical trials. Lancet. 2020; 395(10235):1506-1515.25. Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, et al. Timing of initiation of renalreplacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240-251. Erratum in: N Engl J Med. 2020;383(5):502.26. Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstand;auml;dt H, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN randomized clinical trial. JAMA. 2016;315(20):2190-2199.27. Bourgeois S, Joannes-Boyau O, Honore PM, De Waele E, Vanbelleghem H, Collin V, et al. Technical aspects of continuous renal replacement therapy. In: Critical Care Nephrology. 3rd ed. Elsevier; 2019. p.888-894.e1.28. Palevsky PM, Zhang JH, Oand;rsquo;Connor TZ, Chertow GM, Crowley ST, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7-20.29. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17): 1627-1638.30. Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, et al; DOse REsponse Multicentre International collaborative Initiative (DO-RE-MI Study Group). Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care. 2009;13(2):R57.31. Liu C, Mao Z, Kang H, Hu J, Zhou F. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A metaanalysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20(1):144.32. Li R, Gao X, Zhou T, Li Y, Wang J, Zhang P. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A metaanalysis of randomized controlled trials. Ther Apher Dial. 2022;26(6):1086-1097.33. Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R, et al. A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med. 2015;43(8):1622-1629.34. Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: An updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098-2110.35. Legrand M, Tolwani A. Anticoagulation strategies in continuous renal replacement therapy. Semin Dial. 2021; 34(6):416-422.36. Hu C, Shui P, Zhang B, Xu X, Wang Z, Wang B, et al. How to safeguard the continuous renal replacement therapy circuit: A narrative review. Front Med (Lausanne). 2024;11:1442065.37. Schmidt M, Pellegrino V, Combes A, Scheinkestel C, Cooper DJ, Hodgson C. Mechanical ventilation during extracorporeal membrane oxygenation. Crit Care. 2014; 18(1):203.38. Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: Update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017;43(6):730-749.39. Samoni S, Husain-Syed F, Villa G, Ronco C. Continuous renal replacement therapy in the critically ill patient: From garage technology to artificial intelligence. J Clin Med. 2021;11(1):172.40. Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: A narrative review. Intensive Care Med. 2019; 45(10):1333-1346.41. Thompson Bastin ML, Stromberg AJ, Nerusu SN, Liu LJ, Mayer KP, Liu KD, et al. Association of phosphatecontaining versus phosphate-free solutions on ventilator days in patients requiring continuous kidney replacement therapy. Clin J Am Soc Nephrol. 2022;17(5):634-642.42. Berger MM, Shenkin A, Schweinlin A, Amrein K, Augsburger M, Biesalski HK, et al. ESPEN micronutrient guideline. Clin Nutr. 2022;41(6):1357-1424.43. Jacobs R, Verbrugghe W, Dams K, Roelant E, Couttenye MM, Devroey D, et al. Regional citrate anticoagulation in continuous renal replacement therapy: Is metabolic fear the enemy of logic? A systematic review and metaanalysis of randomised controlled trials. Life (Basel). 2023;13(5):1198.44. Buetti N, Marschall J, Drees M, Fakih MG, Hadaway L, Maragakis LL, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(5):553-569.45. Li L, Li X, Xia Y, Chu Y, Zhong H, Li J, et al. Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Front Pharmacol. 2020; 11:786.46. Oand;rsquo;Dell Duplechin M, Folds GT, Duplechin DP, Ahmadzadeh S, Myers SH, Shekoohi S, et al. Prevention and management of perioperative acute kidney injury: A narrative review. Diseases. 2025;13(9):295.47. Gist KM, Fuhrman DY, Deep A, Haga T, Demirkol D, Bell MJ, et al. Continuous renal replacement therapy: Current state and future directions for worldwide practice. Pediatr Crit Care Med. 2024;25(6):554-560.48. Bhatraju PK, Zelnick LR, Himmelfarb J. Precision medicine in acute kidney injury: Biomarker-defined subphenotypes and their implications for renal replacement therapy timing. Nat Rev Nephrol. 2024;20(2):85-99.49. Snow TAC, Littlewood S, Corredor C, Singer M, Arulkumaran N. Effect of extracorporeal blood purification on mortality in sepsis: A meta-analysis and trial sequential analysis. Blood Purif. 2021;50(4-5): 462-472.50. Putzu A, Schorer R, Lopez-Delgado JC, Cassina T, Landoni G. Blood purification and mortality in sepsis and septic shock: A systematic review and meta-analysis of randomized trials. Anesthesiology. 2019;131(3): 580-593.51. Qiu S, Mu S, Tao Y, Zhang N, Bai J, Cao N. Machine learning model predicts clotting risk during CRRT in ESKD patients: A SHAP-interpretable approach. Ren Fail. 2025;47(1):2562448.52. Dolson GM. The wearable artificial kidney. Methodist Debakey Cardiovasc J. 2020;16(4):324-325.53. Joannidis M, Forni LG, Klein SJ, Honore PM, Kashani K, Ostermann M, et al. Lung-kidney interactions in critically ill patients: Consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med. 2020;46(5):654-672.